Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2014

Preliminary results of aflibercept in treatment naïve choroidal neovascularization of neovascular age-related macular degeneration

Sandrine A Zweifel; Christoph Amstutz; Johannes Fleischhauer; Malaika Kurz-Levin; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3942. doi:

ARVO Annual Meeting Abstract March 2012

Long-term Studies On The Anti-VEGF Treatment Success In Age-related Macular Degeneration (amd)

Barbara Kloeckener-Gruissem; Moreno Menghini; Florian Sutter; Johannes Fleischhauer; Malaika Kurz-Levin; Wolfgang Berger; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5168. doi:

Genetics June 2011

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD

PDF

Barbara Kloeckener-Gruissem; Daniel Barthelmes; Stephan Labs; Christian Schindler; Malaika Kurz-Levin; Stephan Michels; Johannes Fleischhauer; Wolfgang Berger; Florian Sutter; Moreno Menghini
TAGS: exudative age-related macular degeneration, genetics, ranibizumab, single nucleotide polymorphism, genotype, genetic aspects
Invest. Ophthalmol. Vis. Sci.. 2011; 52(7):4694-4702. doi: https://doi.org/10.1167/iovs.10-6080

ARVO Annual Meeting Abstract April 2011

A Swiss Patient Cohort Reveals Genetic Predisposition Of Known And New Genetic Loci To AMD And To Intravitreal Ranibizumab (lucentis®) Treatment Outcome

Barbara Kloeckener-Gruissem; Moreno Menghini; Daniel Barthelmes; Stephan Labs; Malaika Kurz-Levin; Stephan Michels; Johannes Fleischhauer; Florian Sutter; Wolfgang Berger

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5249. doi:

ARVO Annual Meeting Abstract April 2010

Ranibizumab for Exudative Age Related Macular Degeneration - A Comparison of Treatment Results in Centres from Australia and Switzerland

D. Barthelmes; M. Menghini; F. K. P. Sutter; M. M. Kurz-Levin; J. C. Fleischhauer; M. C. Gillies

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):98. doi:

ARVO Annual Meeting Abstract April 2010

Genetic Association of Known Risk Alleles With Different Lesion Types in Age-Related Macular Degeneration

J. C. Fleischhauer; M. Menghini; D. Barthelmes; W. Berger; S. Labs; M. Kurz-Levin; B. Kloeckener-Gruissem; S. Michels; F. Sutter

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1266. doi:

ARVO Annual Meeting Abstract April 2010

Association Between Response to Intravitreal Ranibizumab and Known AMD Susceptibility Loci in Age-Related Macular Degeneration

M. Menghini; F. Sutter; W. Berger; J. Fleischhauer; S. Labs; M. Kurz-Levin; B. Kloeckener-Gruissem; S. Michels; D. Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1284. doi:

ARVO Annual Meeting Abstract April 2009

Normalization of Functional and Anatomic Changes in Carcinoma Associated Retinopathy

S. Michels; D. Barthelmes; C. Amstutz; M. Kurz-Levin

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):338. doi:

ARVO Annual Meeting Abstract May 2008

Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization Not Related to Age-Related Macular Degeneration

S. Michels; F. Sutter; H. Kordic; D. Barthelmes; M. Kurz-Levin

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2722. doi:

ARVO Annual Meeting Abstract May 2008

Towards an Optimized Treatment Scheme of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Subanalysis of Clinical Trial Data and Clinical Routine Use

F. K. Sutter; M. M. Kurz-Levin

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2884. doi:

ARVO Annual Meeting Abstract May 2008

Intravitreal Anti-VEGF Therapy in Von Hippel-Lindau Disease With Retinal Angiomas

M. M. Kurz-Levin; S. Michels; E. Messmer; F. K. Sutter

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5686. doi:

Clinical and Epidemiologic Research April 2007

Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?

PDF

Florian K. P. Sutter; Moreno Menghini; Daniel Barthelmes; Johannes C. Fleischhauer; Malaika M. Kurz-Levin; Martina M. Bosch; Horst Helbig
TAGS: exudative age-related macular degeneration, pseudophakia, risk factors, eye, cataract surgery
Invest. Ophthalmol. Vis. Sci.. 2007; 48(4):1472-1475. doi: https://doi.org/10.1167/iovs.06-0766

ARVO Annual Meeting Abstract May 2006

Prevalence of Cystoid Macular Edema in Cone Dystrophy and Monitoring Treatment Effects of Acetazolamide Using OCT

D. Barthelmes; F.K. Sutter; M.M. Bosch; H. Helbig; M.M. Kurz–Levin; J.C. Fleischhauer

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1048. doi:

ARVO Annual Meeting Abstract May 2006

Exudative Age Related Macular Degeneration Is Not Triggered By Cataract Surgery

H. Helbig; D. Barthelmes; J.C. Fleischhauer; M. Menghini; M.M. Kurz–Levin; M.M. Boesch; F.K. P. Sutter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2098. doi:

ARVO Annual Meeting Abstract May 2006

Cystoid Macular Edema in Patients With Retinitis Pigmentosa: Monitoring Treatment Effects Using OCT

F.K. Sutter; D. Barthelmes; M.M. Bosch; M.M. Kurz–Levin; H. Helbig; J.C. Fleischhauer

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5192. doi:

Retina March 2006

Quantitative Analysis of OCT Characteristics in Patients with Achromatopsia and Blue-Cone Monochromatism

PDF

Daniel Barthelmes; Florian K. Sutter; Malaika M. Kurz-Levin; Martina M. Bosch; Horst Helbig; Günter Niemeyer; Johannes C. Fleischhauer
TAGS: acetylcholine, achondroplasia, achromatopsia, retinal cone
Invest. Ophthalmol. Vis. Sci.. 2006; 47(3):1161-1166. doi: https://doi.org/10.1167/iovs.05-0783

ARVO Annual Meeting Abstract May 2005

Quantitative OCT Imaging in Patients With Cone–Dystrophies

J.C. Fleischhauer; D. Barthelmes; F.K. Sutter; M. Kurz–Levin; M.M. Bosch; G. Niemeyer; H. Helbig

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):544. doi:

ARVO Annual Meeting Abstract May 2005

OCT Imaging in Patients With Achromatopsia and Blue–Cone–Monochromatism – A Quantitative Approach to OCT Scanning Results

D. Barthelmes; J.C. Fleischhauer; M. Kurz–Levin; F.K. Sutter; M.M. Bosch; A. Jehn; G. Niemeyer; H. Helbig

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5233. doi:

ARVO Annual Meeting Abstract May 2003

ABCA4 Variations in Patients with Bull's-eye Maculopathy

M.A. Brantley; M.M. Kurz-Levin; C.G. Easterman; B.R. Roos; G.E. Holder; A.C. Bird; E.M. Stone; A.R. Webster

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3560. doi:

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Preliminary results of aflibercept in treatment naïve choroidal neovascularization of neovascular age-related macular degeneration

Long-term Studies On The Anti-VEGF Treatment Success In Age-related Macular Degeneration (amd)

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD

A Swiss Patient Cohort Reveals Genetic Predisposition Of Known And New Genetic Loci To AMD And To Intravitreal Ranibizumab (lucentis®) Treatment Outcome

Ranibizumab for Exudative Age Related Macular Degeneration - A Comparison of Treatment Results in Centres from Australia and Switzerland

Genetic Association of Known Risk Alleles With Different Lesion Types in Age-Related Macular Degeneration

Association Between Response to Intravitreal Ranibizumab and Known AMD Susceptibility Loci in Age-Related Macular Degeneration

Normalization of Functional and Anatomic Changes in Carcinoma Associated Retinopathy

Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization Not Related to Age-Related Macular Degeneration

Towards an Optimized Treatment Scheme of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Subanalysis of Clinical Trial Data and Clinical Routine Use

Intravitreal Anti-VEGF Therapy in Von Hippel-Lindau Disease With Retinal Angiomas

Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?

Prevalence of Cystoid Macular Edema in Cone Dystrophy and Monitoring Treatment Effects of Acetazolamide Using OCT

Exudative Age Related Macular Degeneration Is Not Triggered By Cataract Surgery

Cystoid Macular Edema in Patients With Retinitis Pigmentosa: Monitoring Treatment Effects Using OCT

Quantitative Analysis of OCT Characteristics in Patients with Achromatopsia and Blue-Cone Monochromatism

Quantitative OCT Imaging in Patients With Cone–Dystrophies

OCT Imaging in Patients With Achromatopsia and Blue–Cone–Monochromatism – A Quantitative Approach to OCT Scanning Results

ABCA4 Variations in Patients with Bull's-eye Maculopathy

To View More...

You must be signed into an individual account to use this feature.